News

Scientists were able to create a bespoke treatment for KJ Muldoon’s rare genetic disorder within six months. It could be a ...
As we continue to see sequencing technologies advance and provide a deeper understanding of gene therapy targets along with ...
QurAlis' FlexASO® platform was developed to generate splice-switching ASOs with improved potency, increased therapeutic index and improved bio-distribution. This bespoke platform has the potential to ...
8 ESF 921 is a culture medium designed for the insect cell baculovirus expression vector system (IC-BEV) technology. It enhances recombinant protein expression, especially glycosylated proteins ...
AbTherx and Single Cell Technology will incorporate Vaccinex's ActivMAb ® Technology into their respective workflows for complex drug targets. AbTherx's antibody discovery platform is built on ...
MOUNTAIN VIEW, CA / ACCESS Newswire / May 13, 2025 / AbTherx, Inc., a biotechnology company with innovative transgenic technologies that simplify and accelerate antibody discovery, today announced a ...
Asos has reaffirmed its intention to “rebalance” investment away from performance marketing towards brand and influencer strategies, as sales at the ecommerce giant continue to slide. The company ...
Asos is a leading European e-commerce player in fashion and cosmetics focusing on the 20-something-year-old demographic segment and specifically strong in its UK home market. Historically, it had ...
The University of Queensland has today announced plans to move ahead with commercialisation of its tin halide perovskite cell technology. Last month, the Australian university revealed that it had ...